Civil Society Listening Session on the U.S. Domestic Response to Female Genital Mutilation/Cutting (FGM/C), 56802 [2014-22574]
Download as PDF
<![CDATA[
56802
Federal Register / Vol. 79, No. 184 / Tuesday, September 23, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Civil Society Listening Session on the
U.S. Domestic Response to Female
Genital Mutilation/Cutting (FGM/C)
Name: Civil Society Listening Session
on the U.S. Domestic Response to
FGM/C.
Date and Time: October 2, 2014, 2:30
p.m.–4:30 p.m.
Place: Hubert H. Humphrey Building,
200 Independence Avenue SW., Room
705A, Washington, DC 20201.
Attendance: Open, but RSVP required
to OGA.RSVP@hhs.gov. If you are a
foreign national, please note this in the
subject line of your RSVP, and our office
will contact you for additional
biographical details to process your
access to the meeting site. RSVP’s must
be received no later than Monday,
September 22, 2014.
Purpose: The U.S. Department of
Health and Human Services (HHS) will
host a civil society listening session on
the U.S. domestic response to FGM/C.
The consultation is an opportunity for
the U.S. government, including
representatives from the White House
and other U.S. federal agencies, to hear
from members of civil society who are
working to address FGM/C domestically
(in the United States). More specifically,
the session will seek to:
• Identify gaps in knowledge
• Identify gaps in services for survivors
and girls at risk
• Identify lessons learned based on
previous efforts
• Share success stories and best
practices at the community level
• Suggest effective outreach strategies
• Make connections and identify
opportunities for increased
collaboration and next steps
Agenda: The session will be
structured around four agenda items: (1)
What is working, (2) lessons learned, (3)
gaps in knowledge, support and
services, and (4) opportunities for
further collaboration between the U.S.
government and civil society.
Participants will be invited to speak for
no more than three minutes on each
topic. At the end of each agenda item,
representatives from relevant federal
agencies will have the opportunity to
briefly respond and ask follow-up
questions.
Participants: All individuals working
on FGM/C in the United States are
invited to attend, including members of:
• Public health and advocacy groups;
• Minority health organizations;
• Refugee and immigrant groups;
• Women’s research, service and
advocacy groups;
VerDate Sep<11>2014
17:55 Sep 22, 2014
Jkt 232001
• Human rights groups;
• Faith-based groups; and
• Academic and scientific
organizations.
Written comments are welcome and
encouraged, even for those who are
planning to attend in person. These
comments should also be sent to
OGA.RSVP@hhs.gov.
Dated: September 9, 2014.
Jimmy Kolker,
Assistant Secretary, Office of Global Affairs.
[FR Doc. 2014–22574 Filed 9–19–14; 11:15 am]
BILLING CODE 4150–38–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Blood and Tissue Safety and
Availability
Office of the Secretary, Office
of the Assistant Secretary for Health,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services is hereby giving notice that the
Advisory Committee on Blood and
Tissue Safety and Availability
(ACBTSA) will hold a meeting. The
meeting will be open to the public.
DATES: The meeting will take place
Thursday, November 13, 2014, from
8:00 a.m. to 3:10 p.m., and Friday,
November 14, 2014, from 8:00 a.m. to
3:45 p.m.
ADDRESSES: Veteran Health
Administration National Conference
Center, 2011 Crystal Drive, Suite 150,
Arlington, VA 22202.
FOR FURTHER INFORMATION CONTACT: Mr.
James Berger, Designated Federal
Officer, ACBTSA, and Senior Advisor
for Blood and Tissue Safety Policy,
Office of HIV/AIDS and Infectious
Disease Policy, Office of the Assistant
Secretary for Health, Department of
Health and Human Services, 1101
Wootton Parkway, Suite 250, Rockville,
MD 20852. Phone: (240) 453–8803; Fax
(240) 453–8456; Email ACBTSA@
hhs.gov.
SUPPLEMENTARY INFORMATION: The
ACBTSA shall provide advice to the
Secretary through the Assistant
Secretary for Health. The Committee
advises on a range of policy issues to
include: (1) Identification of public
health issues through surveillance of
blood and tissue safety issues with
national biovigilance data tools; (2)
identification of public health issues
SUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
that affect availability of blood, blood
products, and tissues; (3) broad public
health, ethical, and legal issues related
to the safety of blood, blood products,
and tissues; (4) the impact of various
economic factors (e.g., product cost and
supply) on safety and availability of
blood, blood products, and tissues; (5)
risk communications related to blood
transfusion and tissue transplantation;
and (6) identification of infectious
disease transmission issues for blood,
organs, blood stem cells and tissues.
The Advisory Committee has met
regularly since its establishment in
1997.
At the November 2014 meeting the
ACBTSA will hear updates on recent
activities of the Department and its
agencies in support of previous
Committee recommendations. Past
recommendations made by the ACBTSA
may be viewed at www.hhs.gov/
bloodsafety.
The focus of the meeting will be to
address the implications of hemoglobin
S testing in blood donors. In particular,
the Committee will focus on the ethics
of hemoglobin S testing as well as the
perspective of affected members of the
blood collecting and using community.
The Committee will also continue its
discussion of the current blood donor
policy for men who have sex with men.
A portion of the meeting will also be
devoted to an emerging infectious
disease, babesia, which could
potentially impact the blood supply.
The public will have opportunities to
present their views to the Committee
during public comment sessions
scheduled for November 13, 2014, and
November 14, 2014. Comments
regarding the men who have sex with
men blood donation policy should be
presented on November 13, 2014.
Comments regarding hemoglobin S
testing and emerging infectious disease
testing should be presented on
November 14, 2014. Comments will be
limited to five minutes per speaker and
must be pertinent to the discussion. Preregistration is required for participation
in the public comment sessions. Any
member of the public who would like to
participate in these sessions is
encouraged to contact the Designated
Federal Officer at his/her earliest
convenience to register for time (limited
to 5 minutes) and registration must be
prior to close of business on November
10, 2014. If it is not possible to provide
30 copies of the material to be
distributed, then individuals are
requested to provide a minimum of one
(1) copy of the document(s) to be
distributed prior to the close of business
on November 10, 2014. It is also
requested that any member of the public
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 79, Number 184 (Tuesday, September 23, 2014)]
[Notices]
[Page 56802]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22574]
[[Page 56802]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Civil Society Listening Session on the U.S. Domestic Response to
Female Genital Mutilation/Cutting (FGM/C)
Name: Civil Society Listening Session on the U.S. Domestic Response
to FGM/C.
Date and Time: October 2, 2014, 2:30 p.m.-4:30 p.m.
Place: Hubert H. Humphrey Building, 200 Independence Avenue SW.,
Room 705A, Washington, DC 20201.
Attendance: Open, but RSVP required to OGA.RSVP@hhs.gov. If you are
a foreign national, please note this in the subject line of your RSVP,
and our office will contact you for additional biographical details to
process your access to the meeting site. RSVP's must be received no
later than Monday, September 22, 2014.
Purpose: The U.S. Department of Health and Human Services (HHS)
will host a civil society listening session on the U.S. domestic
response to FGM/C. The consultation is an opportunity for the U.S.
government, including representatives from the White House and other
U.S. federal agencies, to hear from members of civil society who are
working to address FGM/C domestically (in the United States). More
specifically, the session will seek to:
Identify gaps in knowledge
Identify gaps in services for survivors and girls at risk
Identify lessons learned based on previous efforts
Share success stories and best practices at the community
level
Suggest effective outreach strategies
Make connections and identify opportunities for increased
collaboration and next steps
Agenda: The session will be structured around four agenda items:
(1) What is working, (2) lessons learned, (3) gaps in knowledge,
support and services, and (4) opportunities for further collaboration
between the U.S. government and civil society. Participants will be
invited to speak for no more than three minutes on each topic. At the
end of each agenda item, representatives from relevant federal agencies
will have the opportunity to briefly respond and ask follow-up
questions.
Participants: All individuals working on FGM/C in the United States
are invited to attend, including members of:
Public health and advocacy groups;
Minority health organizations;
Refugee and immigrant groups;
Women's research, service and advocacy groups;
Human rights groups;
Faith-based groups; and
Academic and scientific organizations.
Written comments are welcome and encouraged, even for those who are
planning to attend in person. These comments should also be sent to
OGA.RSVP@hhs.gov.
Dated: September 9, 2014.
Jimmy Kolker,
Assistant Secretary, Office of Global Affairs.
[FR Doc. 2014-22574 Filed 9-19-14; 11:15 am]
BILLING CODE 4150-38-P
